ROLE OF VISFATIN IN THE PATHOGENESIS OF INSULIN RESISTANCE
- Authors: Vulf M.A.1, Skuratovskaya D.A.2, Soboleva A.R.2, Stepanian S.A.2, Kirienkova E.V.2, Litvinova L.S.2
-
Affiliations:
- Immanuel Kant Baltic Federal University Kaliningrad
- Immanuel Kant Baltic Federal University
- Issue: Vol 22, No 4 (2019)
- Pages: 1444-1446
- Section: ORIGINAL ARTICLES
- URL: https://bakhtiniada.ru/1028-7221/article/view/119492
- DOI: https://doi.org/10.31857/S102872210007052-2
- ID: 119492
Cite item
Full Text
Abstract
Keywords
About the authors
M. A. Vulf
Immanuel Kant Baltic Federal University Kaliningrad
Author for correspondence.
Email: mary-jean@yandex.ru
PhD, researcher of Basic Laboratory of Immunology and Cell Biotechnologies,
Kaliningrad
Russian FederationD. A. Skuratovskaya
Immanuel Kant Baltic Federal University
PhD, researcher of Basic Laboratory of Immunology and Cell Biotechnologies,
Kaliningrad
Russian FederationA. R. Soboleva
Immanuel Kant Baltic Federal University
student at the Medical Institute,
Kaliningrad
Russian FederationS. A. Stepanian
Immanuel Kant Baltic Federal University
student at the Medical Institute,
Kaliningrad
Russian FederationE. V. Kirienkova
Immanuel Kant Baltic Federal University
PhD, researcher of Basic Laboratory of Immunology and Cell Biotechnologies,
Kaliningrad
Russian FederationL. S. Litvinova
Immanuel Kant Baltic Federal University
MD, PhD Head of the Laboratory of Immunology and Cell Biotechnologies,
Kaliningrad
Russian FederationReferences
- Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev. 2011 Sep;27(6):515–27. doi: 10.1002/dmrr.1201.
- Wang SN, Miao CY. Targeting NAMPT as a therapeutic strategy against stroke. Stroke Vasc Neurol. 2019 Apr 5;4(2):83–89. doi: 10.1136/svn-2018-000199.
- Lin YT, Chen LK, Jian DY, Hsu TC, Huang WC, Kuan TT, Wu SY, Kwok CF, Ho LT, Juan CC. Visfatin Promotes Monocyte Adhesion by Upregulating ICAM-1 and VCAM-1 Expression in Endothelial Cells via Activation of p38-PI3K-Akt Signaling and Subsequent ROS Production and IKK/NF-κB Activation. Cell Physiol Biochem. 2019;52(6):1398–1411. doi: 10.33594/000000098.
Supplementary files

